Pfizer 1Q Revenues: $18.3 billion (-29%) 1Q Earnings: $5.5 billion (-30%) Comments: Primary care revenues were down 37% to $11.5 billion in the quarter. Specialty care sales were up 8% to $3.6 billion. Oncology sales were down 1% to $2.9 billion. Revenues from Comirnaty and Paxlovid were $7.1 billion in the quarter. Comirnaty sales were $3.1 billion, down 77% and Paxlovid sales were $4.0 billion, up from $1.5 billion 1Q222. Recently acquired products, Nurtec ODT/Vydura and Oxbryta, contribute...